The impact of proactive versus reactive drug monitoring of infliximab on treatment outcomes in patients with crohn's disease

CONCLUSIONS: Proactive TDM of IFX plays a more crucial role in timely adjustment of treatment strategies and maintenance of effective concentrations, thereby contributing to the outcomes for CD patients.PMID:37991266 | DOI:10.1080/00365521.2023.2283387

Source: Scandinavian Journal of Gastroenterology - November 22, 2023 Category: Gastroenterology Authors: Yue Zhang Wenyu Jiang Chenjing Xu Jiahui Tian Jie Chen Hongjie Zhang Source Type: research